20 results on '"Garton N"'
Search Results
2. The impact of acrylonitrile and bioaugmentation on the biodegradation activity and bacterial community structure of a topsoil
- Author
-
Baxter, J., Garton, N. J., and Cummings, S. P.
- Published
- 2006
- Full Text
- View/download PDF
3. Mycobacterial lipid bodies and resuscitation-promoting factor dependency as potential biomarkers of response to chemotherapy.
- Author
-
Garton, N. J., primary, Mukamolova, G. V., additional, and Barer, M. R., additional
- Published
- 2013
- Full Text
- View/download PDF
4. Functional interdependence of BRD4 and DOT1L in MLL leukemia
- Author
-
Gilan, O, Lam, EYN, Becher, I, Lugo, D, Cannizzaro, E, Joberty, G, Ward, A, Wiese, M, Fong, CY, Ftouni, S, Tyler, D, Stanley, K, MacPherson, L, Weng, C-F, Chan, Y-C, Ghisi, M, Smil, D, Carpenter, C, Brown, P, Garton, N, Blewitt, ME, Bannister, AJ, Kouzarides, T, Huntly, BJP, Johnstone, RW, Drewes, G, Dawson, S-J, Arrowsmith, CH, Grandi, P, Prinjha, RK, and Dawson, MA
- Subjects
StemCellInstitute ,3. Good health - Abstract
Targeted therapies against disruptor of telomeric silencing 1-like (DOT1L) and bromodomain-containing protein 4 (BRD4) are currently being evaluated in clinical trials. However, the mechanisms by which BRD4 and DOT1L regulate leukemogenic transcription programs remain unclear. Using quantitative proteomics, chemoproteomics and biochemical fractionation, we found that native BRD4 and DOT1L exist in separate protein complexes. Genetic disruption or small-molecule inhibition of BRD4 and DOT1L showed marked synergistic activity against MLL leukemia cell lines, primary human leukemia cells and mouse leukemia models. Mechanistically, we found a previously unrecognized functional collaboration between DOT1L and BRD4 that is especially important at highly transcribed genes in proximity to superenhancers. DOT1L, via dimethylated histone H3 K79, facilitates histone H4 acetylation, which in turn regulates the binding of BRD4 to chromatin. These data provide new insights into the regulation of transcription and specify a molecular framework for therapeutic intervention in this disease with poor prognosis.
5. Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.
- Author
-
Quintela M, James DW, Pociute A, Powell L, Edwards K, Coombes Z, Garcia J, Garton N, Das N, Lutchman-Singh K, Margarit L, Beynon AL, Rioja I, Prinjha RK, Harker NR, Gonzalez D, Conlan RS, and Francis LW
- Subjects
- Female, Humans, Nuclear Proteins genetics, Nuclear Proteins metabolism, Transcription Factors metabolism, Cell Cycle Proteins genetics, Cell Cycle Proteins metabolism, Cell Line, Tumor, DNA Methylation, Carcinoma, Ovarian Epithelial genetics, Cell Cycle Checkpoints, Apoptosis, DNA Damage, Ovarian Neoplasms drug therapy, Ovarian Neoplasms genetics, Ovarian Neoplasms metabolism, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Carcinoma genetics
- Abstract
Background: Ovarian cancer has a specific unmet clinical need, with a persistently poor 5-year survival rate observed in women with advanced stage disease warranting continued efforts to develop new treatment options. The amplification of BRD4 in a significant subset of high-grade serous ovarian carcinomas (HGSC) has led to the development of BET inhibitors (BETi) as promising antitumour agents that have subsequently been evaluated in phase I/II clinical trials. Here, we describe the molecular effects and ex vivo preclinical activities of i-BET858, a bivalent pan-BET inhibitor with proven in vivo BRD inhibitory activity., Results: i-BET858 demonstrates enhanced cytotoxic activity compared with earlier generation BETis both in cell lines and primary cells derived from clinical samples of HGSC. At molecular level, i-BET858 triggered a bipartite transcriptional response, comprised of a 'core' network of genes commonly associated with BET inhibition in solid tumours, together with a unique i-BET858 gene signature. Mechanistically, i-BET858 elicited enhanced DNA damage, cell cycle arrest and apoptotic cell death compared to its predecessor i-BET151., Conclusions: Overall, our ex vivo and in vitro studies indicate that i-BET858 represents an optimal candidate to pursue further clinical validation for the treatment of HGSC., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
6. Extracting Data from the Electronic Health Record of Patients with ADHD Reveals Pediatricians' Discussions of Educational Support and Document Collection.
- Author
-
Beenen KT, Garton N, Carroll E, Tang A, Berry S, Lee KH, McGoff T, and Soares N
- Subjects
- Humans, Electronic Health Records, Retrospective Studies, Educational Status, Pediatricians, Attention Deficit Disorder with Hyperactivity therapy
- Abstract
Primary care physicians (PCPs) have an important role in the identification and management of Attention Deficit Hyperactivity Disorder (ADHD). There is a paucity of research on PCPs' practices related to the discussion of educational interventions. We conducted a retrospective chart review using Natural Language Processing to extract data on how often PCPs in an outpatient clinic: 1) discuss educational support with patients and caregivers; and 2) obtain educational records. About three-quarters of patients had at least one term related to educational support included in at least one note, but only 13 percent of patients had at least one educational record uploaded into the electronic health record (EHR). There was no association between having an educational document uploaded into the EHR and inclusion of a term related to educational support in a note. Almost half (48 percent) of these records were unclearly labeled. Further education of PCPs is warranted to increase discussions of educational support and obtaining educational records, as is collaboration with health information management professionals around labeling., (Copyright © 2023 by the American Health Information Management Association.)
- Published
- 2023
7. Knot selection in sparse Gaussian processes with a variational objective function.
- Author
-
Garton N, Niemi J, and Carriquiry A
- Abstract
Sparse, knot-based Gaussian processes have enjoyed considerable success as scalable approximations of full Gaussian processes. Certain sparse models can be derived through specific variational approximations to the true posterior, and knots can be selected to minimize the Kullback-Leibler divergence between the approximate and true posterior. While this has been a successful approach, simultaneous optimization of knots can be slow due to the number of parameters being optimized. Furthermore, there have been few proposed methods for selecting the number of knots, and no experimental results exist in the literature. We propose using a one-at-a-time knot selection algorithm based on Bayesian optimization to select the number and locations of knots. We showcase the competitive performance of this method relative to optimization of knots simultaneously on three benchmark datasets, but at a fraction of the computational cost., Competing Interests: The authors declare no conflict of interests., (© 2020 The Authors. Statistical Analysis and Data Mining published by Wiley Periodicals LLC.)
- Published
- 2020
- Full Text
- View/download PDF
8. Multivariate temporal modeling of crime with dynamic linear models.
- Author
-
Garton N and Niemi J
- Subjects
- Chicago, Humans, Linear Models, Crime, Databases, Factual, Models, Theoretical, Police
- Abstract
Interest in modeling contemporary crime trends, a task that has historically been considered valuable to the public, researchers, and policymakers, is resurging. Advancements in criminology have made it clear that understanding crime trends necessarily involves understanding trends in how likely individuals are to report crimes to the police, as well as how likely the police are to accurately record those crimes. In this paper, we use dynamic linear models to simultaneously model the time series for several crime types in order to gain insight into trends in crime and crime reporting. We analyze crime data from Chicago spanning 2007 through 2016 and show how correlations in the way crime trends evolve may contain information about drivers of crime and crime reporting. We provide evidence of substantial differences in the relationships between the trends of crimes of different types depending on whether crimes are violent or nonviolent and whether or not crimes are tracked in the FBI's Uniform Crime Report., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
9. Emergency physician utilization of transvaginal ultrasound after initiation of revised sterilization protocol.
- Author
-
O'Connor TP, Garton N, Jones C, Estephan M, Lu M, and Adler D
- Subjects
- Emergency Service, Hospital statistics & numerical data, Female, Humans, Point-of-Care Systems, Pregnancy, Vagina, Pregnancy, Ectopic diagnostic imaging, Sterilization methods, Ultrasonography statistics & numerical data
- Published
- 2019
- Full Text
- View/download PDF
10. Click chemistry enables preclinical evaluation of targeted epigenetic therapies.
- Author
-
Tyler DS, Vappiani J, Cañeque T, Lam EYN, Ward A, Gilan O, Chan YC, Hienzsch A, Rutkowska A, Werner T, Wagner AJ, Lugo D, Gregory R, Ramirez Molina C, Garton N, Wellaway CR, Jackson S, MacPherson L, Figueiredo M, Stolzenburg S, Bell CC, House C, Dawson SJ, Hawkins ED, Drewes G, Prinjha RK, Rodriguez R, Grandi P, and Dawson MA
- Subjects
- Animals, Benzodiazepines pharmacology, Cells, Cultured, Disease Models, Animal, Leukemia pathology, Mice, Precision Medicine, Tissue Distribution, Transcription Factors antagonists & inhibitors, Benzodiazepines therapeutic use, Click Chemistry, Drug Delivery Systems, Epigenomics, Leukemia drug therapy
- Abstract
The success of new therapies hinges on our ability to understand their molecular and cellular mechanisms of action. We modified BET bromodomain inhibitors, an epigenetic-based therapy, to create functionally conserved compounds that are amenable to click chemistry and can be used as molecular probes in vitro and in vivo. We used click proteomics and click sequencing to explore the gene regulatory function of BRD4 (bromodomain containing protein 4) and the transcriptional changes induced by BET inhibitors. In our studies of mouse models of acute leukemia, we used high-resolution microscopy and flow cytometry to highlight the heterogeneity of drug activity within tumor cells located in different tissue compartments. We also demonstrate the differential distribution and effects of BET inhibitors in normal and malignant cells in vivo. This study provides a potential framework for the preclinical assessment of a wide range of drugs., (Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
- Published
- 2017
- Full Text
- View/download PDF
11. Functional interdependence of BRD4 and DOT1L in MLL leukemia.
- Author
-
Gilan O, Lam EY, Becher I, Lugo D, Cannizzaro E, Joberty G, Ward A, Wiese M, Fong CY, Ftouni S, Tyler D, Stanley K, MacPherson L, Weng CF, Chan YC, Ghisi M, Smil D, Carpenter C, Brown P, Garton N, Blewitt ME, Bannister AJ, Kouzarides T, Huntly BJ, Johnstone RW, Drewes G, Dawson SJ, Arrowsmith CH, Grandi P, Prinjha RK, and Dawson MA
- Subjects
- Acetylation, Animals, B-Lymphocytes metabolism, B-Lymphocytes pathology, Cell Cycle Proteins, Cell Proliferation, Chromatin chemistry, Chromatin metabolism, Clinical Trials as Topic, Disease Models, Animal, Female, Histone-Lysine N-Methyltransferase, Histones metabolism, Humans, Leukemia, Biphenotypic, Acute metabolism, Leukemia, Biphenotypic, Acute pathology, Male, Methyltransferases antagonists & inhibitors, Methyltransferases metabolism, Mice, Mice, Inbred C57BL, Nuclear Proteins antagonists & inhibitors, Nuclear Proteins metabolism, Primary Cell Culture, Protein Binding, Proteomics methods, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, Signal Transduction, T-Lymphocytes metabolism, T-Lymphocytes pathology, Transcription Factors antagonists & inhibitors, Transcription Factors metabolism, Transcription, Genetic, Gene Expression Regulation, Leukemic, Histones genetics, Leukemia, Biphenotypic, Acute genetics, Methyltransferases genetics, Nuclear Proteins genetics, Transcription Factors genetics
- Abstract
Targeted therapies against disruptor of telomeric silencing 1-like (DOT1L) and bromodomain-containing protein 4 (BRD4) are currently being evaluated in clinical trials. However, the mechanisms by which BRD4 and DOT1L regulate leukemogenic transcription programs remain unclear. Using quantitative proteomics, chemoproteomics and biochemical fractionation, we found that native BRD4 and DOT1L exist in separate protein complexes. Genetic disruption or small-molecule inhibition of BRD4 and DOT1L showed marked synergistic activity against MLL leukemia cell lines, primary human leukemia cells and mouse leukemia models. Mechanistically, we found a previously unrecognized functional collaboration between DOT1L and BRD4 that is especially important at highly transcribed genes in proximity to superenhancers. DOT1L, via dimethylated histone H3 K79, facilitates histone H4 acetylation, which in turn regulates the binding of BRD4 to chromatin. These data provide new insights into the regulation of transcription and specify a molecular framework for therapeutic intervention in this disease with poor prognosis.
- Published
- 2016
- Full Text
- View/download PDF
12. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
- Author
-
Westaway SM, Preston AG, Barker MD, Brown F, Brown JA, Campbell M, Chung CW, Drewes G, Eagle R, Garton N, Gordon L, Haslam C, Hayhow TG, Humphreys PG, Joberty G, Katso R, Kruidenier L, Leveridge M, Pemberton M, Rioja I, Seal GA, Shipley T, Singh O, Suckling CJ, Taylor J, Thomas P, Wilson DM, Lee K, and Prinjha RK
- Subjects
- Cell Line, Cell Membrane Permeability, Crystallography, X-Ray, Enzyme Inhibitors pharmacokinetics, Histone Demethylases chemistry, Histone Demethylases metabolism, Humans, Jumonji Domain-Containing Histone Demethylases chemistry, Jumonji Domain-Containing Histone Demethylases metabolism, Models, Molecular, Molecular Docking Simulation, Pyrimidinones pharmacokinetics, Structure-Activity Relationship, Enzyme Inhibitors chemistry, Enzyme Inhibitors pharmacology, Histone Demethylases antagonists & inhibitors, Jumonji Domain-Containing Histone Demethylases antagonists & inhibitors, Pyrimidinones chemistry, Pyrimidinones pharmacology
- Abstract
Following the discovery of cell penetrant pyridine-4-carboxylate inhibitors of the KDM4 (JMJD2) and KDM5 (JARID1) families of histone lysine demethylases (e.g., 1), further optimization led to the identification of non-carboxylate inhibitors derived from pyrido[3,4-d]pyrimidin-4(3H)-one. A number of exemplars such as compound 41 possess interesting activity profiles in KDM4C and KDM5C biochemical and target-specific, cellular mechanistic assays.
- Published
- 2016
- Full Text
- View/download PDF
13. Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice.
- Author
-
Sullivan JM, Badimon A, Schaefer U, Ayata P, Gray J, Chung CW, von Schimmelmann M, Zhang F, Garton N, Smithers N, Lewis H, Tarakhovsky A, Prinjha RK, and Schaefer A
- Subjects
- Animals, Autism Spectrum Disorder genetics, Brain-Derived Neurotrophic Factor pharmacology, Epigenesis, Genetic, Gene Expression drug effects, Male, Mice, Mice, Inbred C57BL, Autism Spectrum Disorder etiology, Nerve Tissue Proteins antagonists & inhibitors, Receptors, Cell Surface antagonists & inhibitors
- Abstract
Studies investigating the causes of autism spectrum disorder (ASD) point to genetic, as well as epigenetic, mechanisms of the disease. Identification of epigenetic processes that contribute to ASD development and progression is of major importance and may lead to the development of novel therapeutic strategies. Here, we identify the bromodomain and extraterminal domain-containing proteins (BETs) as epigenetic regulators of genes involved in ASD-like behaviors in mice. We found that the pharmacological suppression of BET proteins in the brain of young mice, by the novel, highly specific, brain-permeable inhibitor I-BET858 leads to selective suppression of neuronal gene expression followed by the development of an autism-like syndrome. Many of the I-BET858-affected genes have been linked to ASD in humans, thus suggesting the key role of the BET-controlled gene network in the disorder. Our studies suggest that environmental factors controlling BET proteins or their target genes may contribute to the epigenetic mechanism of ASD., (© 2015 Sullivan et al.)
- Published
- 2015
- Full Text
- View/download PDF
14. Discovery of biaryl inhibitors of H+/K+ ATPase.
- Author
-
Garton N, Bailey N, Bamford M, Demont E, Farre-Gutierrez I, Hutley G, Bravi G, and Pickering P
- Subjects
- H(+)-K(+)-Exchanging ATPase metabolism, Imidazoles metabolism, Imidazoles pharmacology, Structure-Activity Relationship, Drug Discovery methods, Imidazoles chemistry, Proton Pump Inhibitors
- Abstract
We report the identification of a novel biaryl template for H(+)/K(+) ATPase inhibition. Evaluation of critical SAR features within the biaryl imidazole framework and the use of pharmacophore modelling against known imidazopyridine and azaindole templates suggested that the geometry of the molecule is key to achieving activity. Herein we present our work optimising the potency of the molecule through modifications and substitutions to each of the ring systems. In particular sub-micromolar potency is achieved with (4b) presumably through a proposed intramolecular hydrogen bond that ensures the required imidazole basic centre is appropriately located., (Copyright (c) 2009 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
15. Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs).
- Author
-
Panchal T, Bailey N, Bamford M, Demont E, Elliott R, Farre-Gutierrez I, Garton N, Hayhow T, Hutley G, and Naylor A
- Subjects
- Binding, Competitive, Drug Design, Heterocyclic Compounds chemical synthesis, Heterocyclic Compounds chemistry, Molecular Structure, Pyridines chemical synthesis, Pyridines chemistry, Stereoisomerism, Structure-Activity Relationship, Heterocyclic Compounds pharmacology, Proton Pump Inhibitors, Pyridines pharmacology
- Abstract
A variety of basic, heterocyclic templates has been reported as potassium-competitive, acid pump antagonists. Herein, we report a comparison of potencies of these templates and others to establish which offers the best start point for further systematic optimisation. Modifications were carried out to improve the developability profile of the more potent 1H-pyrrolo[2,3-c]pyridine template, affording molecules with improved overall in vitro characteristics versus the reported clinical candidate AR-H047108, and comparable to the clinically efficacious AZD-0865.
- Published
- 2009
- Full Text
- View/download PDF
16. Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs).
- Author
-
Bailey N, Bamford MJ, Brissy D, Brookfield J, Demont E, Elliott R, Garton N, Farre-Gutierrez I, Hayhow T, Hutley G, Naylor A, Panchal TA, Seow HX, Spalding D, and Takle AK
- Subjects
- Administration, Oral, Animals, Dogs, H(+)-K(+)-Exchanging ATPase metabolism, Humans, Hydrogen-Ion Concentration, Pyridines chemical synthesis, Pyridines pharmacology, Rats, Structure-Activity Relationship, Proton Pump Inhibitors chemical synthesis, Proton Pump Inhibitors chemistry, Proton Pump Inhibitors pharmacology, Pyridines chemistry
- Abstract
Acid pump antagonists (APAs) such as the imidazo[1,2-a]pyridine AZD-0865 2 have proven efficacious at low oral doses in acid related gastric disorders. Herein we describe some of the broader SAR in this class of molecule and detail the discovery of an imidazo[1,2-a]pyridine 15 which has excellent efficacy in animal models of gastric acid secretion following oral administration, as well as a good overall developability profile. The discovery strategy focuses on use of heteroaryl and heterocyclic substituents at the C-6 position and optimization of developability characteristics through modulation of global physico-chemical properties.
- Published
- 2009
- Full Text
- View/download PDF
17. Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.
- Author
-
Witherington J, Blaney EL, Bordas V, Elliott RL, Gaiba A, Garton N, Green PM, Naylor A, Smith DG, Spalding DJ, Takle AK, and Ward RW
- Subjects
- Administration, Oral, Animals, Pyridones administration & dosage, Pyridones pharmacokinetics, Rats, Integrin alpha4beta1 antagonists & inhibitors, Pyridones pharmacology
- Abstract
A series of pyridone-N-benzyl-propanoic acids have been optimised to afford potent orally bioavailable VLA-4 antagonists.
- Published
- 2006
- Full Text
- View/download PDF
18. The cell wall of the pathogenic bacterium Rhodococcus equi contains two channel-forming proteins with different properties.
- Author
-
Riess FG, Elflein M, Benk M, Schiffler B, Benz R, Garton N, and Sutcliffe I
- Subjects
- Animals, Bacterial Proteins, Blotting, Western, Humans, Lipid Bilayers chemistry, Membrane Potentials, Molecular Weight, Phosphatidylcholines, Phosphatidylserines, Porins chemistry, Cell Wall chemistry, Ion Channels analysis, Porins isolation & purification, Rhodococcus equi chemistry
- Abstract
We have identified in organic solvent extracts of whole cells of the gram-positive pathogen Rhodococcus equi two channel-forming proteins with different and complementary properties. The isolated proteins were able to increase the specific conductance of artificial lipid bilayer membranes made from phosphatidylcholine-phosphatidylserine mixtures by the formation of channels able to be permeated by ions. The channel-forming protein PorA(Req) (R. equi pore A) is characterized by the formation of cation-selective channels, which are voltage gated. PorA(Req) has a single-channel conductance of 4 nS in 1 M KCl and shows high permeability for positively charged solutes because of the presence of negative point charges. According to the results of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the protein has an apparent molecular mass of about 67 kDa. The analysis (using the effect of negative charges on channel conductance) of the concentration dependence of the single-channel conductance suggested that the diameter of the cell wall channel is about 2.0 nm. The second channel (formed by PorB(Req) [R. equi pore B]) shows a preferred movement of anions through the channel and is not voltage gated. This channel shows a single-channel conductance of 300 pS in 1 M KCl and is characterized by the presence of positive point charges in or near the channel mouth. Based on SDS-PAGE, the apparent molecular mass of the channel-forming protein is about 11 kDa. Channel-forming properties of the investigated cell wall porins were compared with those of others isolated from mycolic acid-containing actinomycetes. We present here the first report of a fully characterized anion-selective cell wall channel from a member of the order Actinomycetales.
- Published
- 2003
- Full Text
- View/download PDF
19. Fluorescence and Brightfield Cytology of Live M. tuberculosis Cells.
- Author
-
Cooney RP, Garton NJ, and Barer MR
- Abstract
Although light microscopy fell out of favor as a research tool in prokaryotic biology in the 1980s, advances in the reagents available for cell labeling (staining) and in the user-friendliness of microscopes were underpinning a revolution in eukaryotic cell biology. The development of epifluorescence hardware, particularly confocal microscopy and low-light imaging systems, and computational deblurring and video enhancement methodologies, substantially extended the range of potential applications. These developments now enable us to detect weaker signals at higher levels of resolution than was previously possible. Finally the personal computer and related software developments have brought image analysis within affordable range for many laboratories and facilitate quantitation of cellular properties on an objective basis. We have sought to apply these advances across a range of prokaryotic applications and here we describe the methods we have applied to live Mycobacterium tuberculosis cells. Although we have principally been concerned with two applications, the determination of viability at the cellular level (see Note 1) and the nature and distribution of lipid domains, more general aspects of light microscopic cytological analyses are discussed below.
- Published
- 2001
- Full Text
- View/download PDF
20. Lipid domains of mycobacteria studied with fluorescent molecular probes.
- Author
-
Christensen H, Garton NJ, Horobin RW, Minnikin DE, and Barer MR
- Subjects
- Cell Membrane metabolism, Microbiological Techniques instrumentation, Microscopy, Confocal, Mycobacterium immunology, Mycobacterium avium cytology, Mycobacterium avium metabolism, Mycobacterium smegmatis cytology, Mycobacterium smegmatis metabolism, Mycobacterium tuberculosis cytology, Mycobacterium tuberculosis metabolism, Polysorbates pharmacology, Surface-Active Agents pharmacology, Fluorescent Dyes chemistry, Lipid Metabolism, Mycobacterium metabolism
- Abstract
The complex mycobacterial cell envelope is recognized as a critical factor in our failure to control tuberculosis, leprosy and other non-tuberculous pathogens. Although its composition has been extensively determined, many details regarding the organization of the envelope remain uncertain. This is particularly so for the non-covalently bound lipids, whose natural distribution may be disrupted by conventional biochemical or cytological techniques. In order to study the native organization of lipid domains in the mycobacterial envelope, we have applied a range of fluorescent lipophilic probes to live mycobacteria, including Mycobacterium smegmatis, Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium gadium and Mycobacterium aurum, and analysed the resultant signals by fluorescence microscopy and digital image processing. Five key features were observed: (i) the presence of both envelope and intracellular lipid domains; (ii) differential localization of probes into these domains influenced predominantly by their hydrophobicity, as modelled by their calculated octanol:water partition coefficients and by their amphiphilicities; (iii) uneven distribution of lipophilic material in the envelope; (iv) selective labelling of septal regions of the envelope; and (v) modification of labelling patterns by additional treatments such as fluorescence quenching antibodies, detergents and solvents. Using this last approach, a coherent cell envelope lipid domain was demonstrated outside the cytoplasmic membrane and, for the first time, the proposed covalently linked mycolyl-arabinogalactan-peptidoglycan macromolecular complex was imaged directly. The use of fluorescent probes and high-resolution fluorescence microscopy has enabled us to obtain a coherent view of distinct lipid domains in mycobacteria. Further application of this approach will facilitate understanding of the role of lipids in the physiology of these organisms.
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.